Cargando…
Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months
BACKGROUND: Prognostication is very important to clinicians and families during the early management of severe traumatic brain injury (sTBI), however, there are no gold standard biomarkers to determine prognosis in sTBI. As has been demonstrated in several diseases, early measurement of serum metabo...
Autores principales: | Banoei, Mohammad M., Lee, Chel Hee, Hutchison, James, Panenka, William, Wellington, Cheryl, Wishart, David S., Winston, Brent W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363297/ https://www.ncbi.nlm.nih.gov/pubmed/37481590 http://dx.doi.org/10.1186/s13054-023-04573-9 |
Ejemplares similares
-
Metabolomics in severe traumatic brain injury: a scoping review
por: Fedoruk, Riley Page, et al.
Publicado: (2023) -
How Do Scores on the Functional Status Examination (FSE) Correspond to Scores on the Glasgow Outcome Scale-Extended (GOSE)?
por: Nelson, Lindsay D., et al.
Publicado: (2022) -
Metabolomic and metallomic profile differences between Veterans and Civilians with Pulmonary Sarcoidosis
por: Banoei, Mohammad Mehdi, et al.
Publicado: (2019) -
Towards clinical management of traumatic brain injury: a review of models and mechanisms from a biomechanical perspective
por: Namjoshi, Dhananjay R., et al.
Publicado: (2013) -
Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia
por: Banoei, Mohammad M., et al.
Publicado: (2017)